These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 36515360)
1. A role for HLA in mediating long-term multiple sclerosis outcomes? Jokubaitis VG Mult Scler; 2023 Mar; 29(3):314-316. PubMed ID: 36515360 [No Abstract] [Full Text] [Related]
2. Frequency of HLA-DRB1 gene alleles in patients with multiple sclerosis in a Lithuanian population. Balnytė R; Rastenytė D; Mickevičienė D; Vaitkus A; Skrodenienė E; Vitkauskienė A Medicina (Kaunas); 2012; 48(1):9-14. PubMed ID: 22370504 [TBL] [Abstract][Full Text] [Related]
3. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442 [TBL] [Abstract][Full Text] [Related]
4. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population. Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906 [TBL] [Abstract][Full Text] [Related]
5. Comment: the HLA region in multiple sclerosis. Goris A Neurology; 2012 Aug; 79(6):544. PubMed ID: 22786602 [No Abstract] [Full Text] [Related]
6. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring. Guijarro-Castro C; Sanchez-Zapardiel E; Munoz D; Fernandez O; Leyva L; Castro-Panete MJ; Picon-Munoz C; Talise M; Martinez-Feito A; Paz-Artal E Rev Neurol; 2016 Sep; 63(5):201-5. PubMed ID: 27569565 [TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the Middle East North Africa region: A systematic review and meta-analysis. Mohajer B; Abbasi N; Pishgar F; Abdolalizadeh A; Ebrahimi H; Razaviyoun T; Mohebbi F; Eskandarieh S; Sahraian MA J Neuroimmunol; 2018 Aug; 321():117-124. PubMed ID: 29957381 [TBL] [Abstract][Full Text] [Related]
8. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784 [TBL] [Abstract][Full Text] [Related]
9. Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. Link J; Kockum I; Lorentzen AR; Lie BA; Celius EG; Westerlind H; Schaffer M; Alfredsson L; Olsson T; Brynedal B; Harbo HF; Hillert J PLoS One; 2012; 7(5):e36779. PubMed ID: 22586495 [TBL] [Abstract][Full Text] [Related]
10. Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis. Disanto G; Hall C; Lucas R; Ponsonby AL; Berlanga-Taylor AJ; Giovannoni G; Ramagopalan SV; Mult Scler; 2013 Sep; 19(10):1355-8. PubMed ID: 23413297 [TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort. Katsavos S; Artemiadis A; Gontika M; Skarlis C; Markoglou N; Davaki P; Stamboulis E; Kilindireas K; Stefanis L; Anagnostouli M Postgrad Med; 2019 Sep; 131(7):490-495. PubMed ID: 31408393 [No Abstract] [Full Text] [Related]
12. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations. Alcina A; Abad-Grau Mdel M; Fedetz M; Izquierdo G; Lucas M; Fernández O; Ndagire D; Catalá-Rabasa A; Ruiz A; Gayán J; Delgado C; Arnal C; Matesanz F PLoS One; 2012; 7(1):e29819. PubMed ID: 22253788 [TBL] [Abstract][Full Text] [Related]
14. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis. Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586 [TBL] [Abstract][Full Text] [Related]
15. The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 status. Hedström AK; Hössjer O; Hillert J; Stridh P; Kockum I; Olsson T; Alfredsson L Mult Scler; 2020 Nov; 26(13):1638-1646. PubMed ID: 31573825 [TBL] [Abstract][Full Text] [Related]
16. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients. Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147 [TBL] [Abstract][Full Text] [Related]
17. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis. Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765 [TBL] [Abstract][Full Text] [Related]
18. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965 [TBL] [Abstract][Full Text] [Related]
19. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501. Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]